The Times Australia
The Times News

.
Times Media

.

9 reasons you can be optimistic that a vaccine for COVID-19 will be widely available in 2021

  • Written by William Petri


As fall approaches rapidly, many are wondering if the race for a vaccine will bear fruit as early as January 2021.

I am a physician-scientist and infectious diseases specialist at the University of Virginia, where I care for patients and conduct research into COVID-19. I am occasionally asked how I can be sure that researchers will develop a successful vaccine to prevent COVID-19. After all, we still don’t have one for HIV, the virus that causes AIDS.

Here is where the current research stands, where I think we will be in five months and why you can be optimistic about the delivery of a COVID-19 vaccine.

1. Human immune system cures COVID-19

In as many as 99% of all COVID-19 cases, the patient recovers from the infection, and the virus is cleared from the body.

Some of those who have had COVID-19 may have low levels of virus in the body for up to three months after infection. But in most cases these individuals can no longer transmit the virus to other people 10 days after first becoming sick.

It should therefore be much easier to make a vaccine for the new coronavirus than for infections such as HIV where the immune system fails to cure it naturally. SARS-CoV-2 doesn’t mutate the way that HIV does, making it a much easier target for the immune system to subdue or for a vaccine to control.

2. Antibodies targeting spike protein prevent infection

A vaccine will protect, in part, by inducing the production of antibodies against the spike protein on the surface of SARS-CoV-2, the virus that causes COVID-19.

Y-shaped antibody bound to the spike protein.
When a Y-shaped antibody (green) binds to the spike protein (blue and brown) of the SARS-CoV-2, the coronavirus is unable to infect cells. vdvornyk/iStock/Getty Images Plus

The virus needs the spike protein to attach to and enter human cells to reproduce. Researchers have shown that antibodies, like those made by the human immune system, bind to the spike protein, neutralize it and prevent the coronavirus from infecting cells in laboratory culture.

Vaccines in clinical trials have been shown to raise anti-spike antibodies that block virus infection in cells in the lab.

At least seven companies have developed monoclonal antibodies, laboratory-manufactured antibodies that recognize the spike protein. These antibodies are entering clinical trials to test their ability to prevent infection in those who are exposed, for example, through a household contact.

Monoclonal antibodies may also be effective for treatment. During an infection, a dose of these monoclonal antibodies could neutralize virus, giving the immune system a chance to catch up and manufacture its own antibodies to combat the pathogen.

3. Spike glycoprotein contains multiple targets

The spike protein has many locations where antibodies can bind to and neutralize the virus. That’s good news because with so many vulnerable spots, it will be difficult for the virus to mutate to avoid a vaccine.

Multiple parts of the spike would need to mutate to evade neutralizing anti-spike antibodies. Too many mutations to the spike protein would change its structure and render it incapable of binding to ACE2, which is key to infecting human cells.

4. We know how to make a safe vaccine

Safety of a new COVID-19 vaccine is improved by researchers’ understanding of potential vaccine side effects and how to avoid them.

One side effect seen in the past was antibody-dependent enhancement of infection. This occurs when antibodies don’t neutralize the virus but instead allow it to enter into cells via a receptor intended for antibodies. Researchers have found that by immunizing with the spike protein, high levels of neutralizing antibodies can be produced. This lessens the risk of enhancement.

A second potential problem posed by some vaccines is an allergic reaction that causes inflammation in the lung, as was seen in individuals who received a respiratory syncytial virus vaccine in the 1960s. This is dangerous because inflammation in the lung air spaces can make it difficult to breathe. However, researchers have now learned how to design vaccines to avoid this allergic response.

5. Several different vaccines in development

The U.S. government is supporting the development of several different vaccines via Operation Warp Speed.

The goal of Operation Warp Speed is to deliver 300 million doses of a safe and effective vaccine by January 2021.

The U.S. government is making a major investment, committing US$8 billion to seven different COVID-19 vaccines.

By supporting multiple COVID-19 vaccines, the government is hedging its bets. Only one of these vaccines needs to prove safe and effective in clinical trials for a COVID-19 vaccine to be made available to Americans in 2021.

[Get the best of The Conversation, every weekend. Sign up for our weekly newsletter.]

6. Vaccines passing through phase I and II trials

Phase I and phase II trials test if a vaccine is safe and induces an immune response. Already the results to date from three different vaccine trials are promising, triggering the production of anti-spike neutralizing antibodies levels that are two- to four-fold higher than those seen in people who have recovered from COVID-19.

Moderna, Oxford and Chinese company CanSino have all demonstrated the safety of their vaccines in phase I and phase II trials.

Phase III trials for a COVID-19 vaccine are underway in multiple countries. ER Productions Limited/Getty Images

7. Phase III clinical trials are underway

During a phase III trial, the final step in vaccine development process, the vaccine is tested on tens of thousands of individuals to determine if it works to prevent infection with SARS-CoV-2, and that it is safe.

The vaccine produced by Moderna and NIH and the vaccine from Oxford-AstraZeneca began phase III trials in July. Other COVID-19 vaccines will be starting phase III within weeks.

8. Accelerating vaccine production and deployment

Operation Warp Speed is paying for the production of millions of doses of vaccines and supporting vaccine manufacturing at an industrial scale even before researchers have demonstrated vaccine efficacy and safety.

The advantage of this strategy is that once a vaccine is proven safe in phase III trials, a stockpile of it will already exist and it can be distributed immediately without compromising full assessment of safety and efficacy.

This is a more prudent approach than that of Russia, which is vaccinating the public with a vaccine before it has been shown to be safe and effective in phase III.

9. Vaccine distributors are being contracted now

McKesson Corp., the largest vaccine distributor in the U.S., has already been contracted by the CDC to distribute a COVID-19 vaccine to sites – including clinics and hospitals – where the vaccine will be administered.

I believe that it is realistic that we will know sometime in late 2020 whether some COVID-19 vaccines are safe, exactly how effective they are and which ones should be used to vaccinate the U.S. population in 2021.

This article first appeared in The Conversation. It is republished with permisision

The Times Features

Maintaining Your Pool After a Marble Interior Upgrade

After upgrading your pool with a marble interior, it’s crucial to understand that maintenance is key to preserving its elegance and longevity. You’ll want to regularly skim for d...

Labor using explanatory document to hide true powers of Misinformation Bill

The opinions and commentary of individuals could be deemed misinformation under Labor’s proposed legislation changes, according to James McComish of Victorian Bar. Appearing in...

Hotel Indigo launches limited-edition candle collection inspired by local neighbourhoods across ANZ

Hotel Indigo, part of IHG Hotels & Resorts' luxury and lifestyle portfolio, is releasing a limited-edition candle collection inspired by the unique neighbourhoods its hotel...

Kyndryl ANZ appoints new Head of Strategic Partnerships and Alliances

Former Head of Marketing to lead and grow Kyndryl’s local channel ecosystem and bolster technological capabilities Kyndryl has strengthened its local leadership team with the ...

Posh picnics the Sunshine Coast helicopter picnic tour

Oceanview Helicopters launches Picnic on a Peak celebrating Sunshine Coast local food and views Oceanview Helicopters has launched a new tour in preparation for the upcoming s...

Sunshine Coast Personal Injury Lawyers: Expert Guidance for Work Accident Claims

When accidents occur in the workplace, they can have profound and lasting effects on a worker's life, both physically and financially. In Queensland's Sunshine Coast, personal in...

iS Clinical's Skincare Secrets for Radiant Party Season Skin

As the festive season approaches, having runway-ready skin is easier than ever with iS Clinical's  top skincare prep tips. Whether you're walking the red carpet or simply stepp...

How to Camp Sustainably in Byron Bay: Eco-Friendly Tips

Camping in Byron Bay is a fantastic way to soak up nature, from beautiful beaches to lush rainforests. It’s no wonder Byron Bay camping is on so many bucket lists! But with more ...

Book a room in Broome as the northwest is best

Looking for a different kind of seaside escape? Done the east coast? Then book a room in Broome to discover why those in the know say the northwest is best, with Broome one of ...

Times Magazine

Truck Dealers Sales and Service: Get the Best Deals on Trucks Here

Looking for the best deals on trucks near you? Truck repair shops in Australia offer a range of services and sales options that can help you get the perfect truck for your needs.  Whether you're looking for a new or used one, these professional ...

Seiko 5 Sports Celebrates 55 years With a Special Creation Honouring Bruce Lee

First introduced in 1968, the Seiko 5 Sports collection has brought durable and reliable mechanical watches to watch lovers around the world. In commemoration of the 55th anniversary of the collecti...

Aussie small business owner fights global Zoom fatigue with new tech

Stuck in back-to-back meetings and need the loo? A Brisbane start-up has the antidote for your work from home (WFH) woes, including a clever video loop (“On Hold”), so you can sneak away from your Zoom calls without anybody realising.  With mo...

Bridesmaid Duties: What To Do for the Bride

There’s no greater privilege than being chosen as a bridesmaid. Of course, you can’t help feeling joy and excitement with your friend getting married. However, a feeling of anxiety may also creep up on you if you don’t know what to do or if you fee...

Waave launches ‘Wallet’ for Pay by Bank with Australian-first biometric security

Payments technology and Open Banking leader Waave today announces the introduction of the Waave Wallet to house its upgraded Pay by Bank product, a real-time account-to-account payment method which now features industry-leading biometric security...

The Ultimate Pet Handbook

An essential guide for young people with a passion for pets  “As you read this book it will soon be obvious that Ben Dessen is no ordinary individual. From a very young age Ben has had a fascination with animals of all kinds. He has the greatest e...